original articlebreast cancerTrastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines
breast cancer
Under an Elsevier user license
open archive
Keywords
ADCC
ERBB2
HER-2 low
HER-2-non-amplified breast cancer
trastuzumab
Cited by (0)
Copyright © 2011 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.